Literature DB >> 35139275

Marginal-Zone Lymphomas.

Davide Rossi1, Francesco Bertoni1, Emanuele Zucca1.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35139275     DOI： 10.1056/NEJMra2102568

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

1.  A roadmap for clinical trial design in marginal zone lymphoma.

Authors:  Juan Pablo Alderuccio; Thomas Habermann; Russ Kuker; Craig H Moskowitz; Andrew D Zelenetz; Izidore S Lossos
Journal:  Am J Hematol       Date:  2022-09-12       Impact factor: 13.265

Review 2.  Extranodal Marginal Zone Lymphoma: Pathogenesis, Diagnosis and Treatment.

Authors:  Alice Di Rocco; Luigi Petrucci; Giovanni Manfredi Assanto; Maurizio Martelli; Alessandro Pulsoni
Journal:  Cancers (Basel)       Date:  2022-03-29       Impact factor: 6.639

3.  Prospective Study of 4 Gy Radiotherapy for Orbital Mucosa-Associated Lymphoid Tissue Lymphoma (FORMAL).

Authors:  Jaehyeon Park; Ji Woon Yea; Se An Oh; Min Kyoung Kim; Jun Hyuk Son; Jae Won Park
Journal:  Cancers (Basel)       Date:  2022-09-01       Impact factor: 6.575

4.  Misdiagnosis of primary mucosa-associated lymphoid tissue lymphoma of the pleura: case report and literature review.

Authors:  Yao-Hui Wang; Ling Peng; Jie-Han Jiang; Yun Xiao; Zhi-Ruo Zhu; Zhi-Hui Shi; Wen-Long He; Qing-Wu Qin; Ding Liang; Yi Jiang; Hong Luo; Rui Zhou; Kui Xiao
Journal:  Transl Cancer Res       Date:  2022-09       Impact factor: 0.496

Review 5.  Marginal Zone B-Cell Populations and Their Regulatory Potential in the Context of HIV and Other Chronic Inflammatory Conditions.

Authors:  Kim Doyon-Laliberté; Matheus Aranguren; Johanne Poudrier; Michel Roger
Journal:  Int J Mol Sci       Date:  2022-03-21       Impact factor: 5.923
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.